今回開発した新Direct-SATORI法では、検査試薬および手順を一から最適化することで、mRNA薬剤から遺伝子を効率よく取り出す工程をSATORI法に統合するとともに、血液中に含まれる多様な成分による影響を最小限に抑える独自の検査手法を構築しました。これにより、血液中のmRNA薬剤を10分以内という短時間で高感度に検出することに成功しました。一例として、赤血球の産生を促す造血因子（EPO）をコ ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

2020年10月、ゲノム編集の新手法であるCRISPR-Cas9が、ノーベル化学賞を受賞したことを受け、NHK出版刊行『ゲノム編集の衝撃』の重版が決定しました。また増刷に合わせ、同書を執筆した取材班への緊急インタビューもWEBマガジン「本がひらく」にて公開 ...

SEOUL, South Korea, Nov. 19, 2025 /PRNewswire/ -- ToolGen (KOSDAQ: 199800; CEO Jong-sang Ryu), a leader in genome editing technology, announced that the United States Patent and Trademark Office has ...

Scientists have developed a novel approach of genome editing to repair muscle stem (satellite) cells, offering new hope for ...

SAN DIEGO & BRISBANE, Calif.--(BUSINESS WIRE)--VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, ...

Here are five medical breakthroughs that gave us hope in 2025. In February, a baby with a rare, often fatal genetic disorder ...

最近開発されたCRISPR/Cas9システムの使用により、遺伝子変異マウスの作製に必要な時間は大幅に短縮された。しかしながら ...

The global CRISPR technology market is poised for strong expansion, projected to grow at a robust CAGR of approximately 16% over the next five years. This growth is fueled by continuous advancements ...

Discover how scientists are harnessing the power of CRISPR to precisely edit DNA, revolutionizing medicine and ethics as they rewrite the very code of life. Pixabay, PublicDomainPictures CRISPR ...

- U.S. patent granted for CRISPR-Cas9 RNP platform technology in the world's largest biotech market - Next-generation platform that enhances editing efficiency and accuracy strengthens ToolGen's ...